TransMedics initiated with Hold at Stifel on mixed survey results

3 hours ago 1

TransMedics (NASDAQ:TMDX) shares fell on Thursday after Stifel launched the organ care provider with a Hold recommendation, citing mixed results from a survey it conducted among 19 U.S. transplant surgeons.
The survey results indicated that organ utilization expansion should continue